MTOR and lung cancer: The mammalian target of rapamycin (mTOR) pathway is a crucial pivot in cancer promotion and the mTOR-miR-143/HK2 axis could accelerate tumor proliferation and formation by promoting glucose metabolism in lung cancer [27].